Overview
What is Drugs For Neglected Diseases Initiative North America Inc?
Drugs For Neglected Diseases Initiative North America Inc is a nonprofit organization based in New York City, specifically at 40 Rector Street 16th Floor, NY 10006. Their primary mission is to support the research and development (R&D) activities of the Drugs for Neglected Diseases Initiative (DNDI), a global organization dedicated to developing new drugs or formulations for patients suffering from neglected diseases. By bridging existing R&D gaps in essential drugs for these diseases, DNDI North America contributes to the goal of delivering 25 new treatments for neglected patients by 2028 and establishing a robust pipeline of new potential drug candidates. As of now, they have over 30 projects in their pipeline, including over 20 potential new chemical entities (NCES), and have delivered 12 treatments for six deadly diseases that are currently in use by millions of patients. They aim to strengthen and expand DNDI's scientific, policy advocacy, fundraising, and communications efforts in North America through focused support for specific R&D projects, policy changes, fundraising, and increasing DNDI's profile and visibility in the region.
Official website here: www.dndina.org
Is Drugs For Neglected Diseases Initiative North America Inc legitimate?
Drugs For Neglected Diseases Initiative North America Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Drugs For Neglected Diseases Initiative North America Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $274,995
Professional Fundraising Fees: $0
Other Salaries and Wages: $959,267
For more financial information, click here
Official website here: www.dndina.org
What is the mission statement of Drugs For Neglected Diseases Initiative North America Inc?
The Drugs for Neglected Diseases Initiative North America (DNDI NA) supports DNDI's global mission to develop new drugs or improved formulations for patients suffering from neglected diseases. Acting in the public interest, DNDI NA bridges existing research and development gaps in essential drugs for these diseases by initiating and coordinating drug research projects in collaboration with the international research community, the public sector, the pharmaceutical industry, and other partners.
The mission of DNDI NA is to contribute to the achievement of DNDI's global objectives. It aims to strengthen and expand DNDI's scientific, policy advocacy, fundraising, and communications efforts in North America by providing focused support for specific research projects and business/partner development activities, achieving concrete policy changes to create a more favorable environment for needs-driven research for neglected diseases, mobilizing public and private funds to support DNDI's mission, and increasing DNDI's profile and visibility in North America to draw greater public attention to the need for neglected disease research and development.
Official website here: www.dndina.org
What is the revenue of Drugs For Neglected Diseases Initiative North America Inc?
Drugs For Neglected Diseases Initiative North America Inc's revenue in 2023 was $4,350,936.
Official website here: www.dndina.org
Who are the executives of Drugs For Neglected Diseases Initiative North America Inc and what are their salaries?
The average compensation at Drugs For Neglected Diseases Initiative North America Inc during 2023 was $123,426. There are 10 employees and 8 volunteers at Drugs For Neglected Diseases Initiative North America Inc.
Here are 12 key members and their salaries:
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $212,616
- Related: $0
- Other: $62,379
- Compensation: $154,284
- Related: $0
- Other: $12,590
- Compensation: $131,386
- Related: $0
- Other: $40,300
- Compensation: $113,013
- Related: $0
- Other: $58,932
Official website here: www.dndina.org
Where can I find the form 990 for Drugs For Neglected Diseases Initiative North America Inc?
Drugs For Neglected Diseases Initiative North America Inc's most recent form 990 was submitted in 2023 and can be accessed here.
Official website here: www.dndina.org
Learn more at the official website: www.dndina.org
Mission Statement of Drugs For Neglected Diseases Initiative North America Inc
Drugs For Neglected Diseases Initiative North America Inc, abbreviated as DNDI North America, is committed to advancing the global mission of DNDI by developing new drugs or improving existing formulations for patients suffering from neglected diseases. Acting in the public interest, DNDI North America bridges existing research and development gaps in essential drugs for these diseases by initiating and coordinating drug research projects in collaboration with the international research community, the public sector, the pharmaceutical industry, and other partners.
The primary mission of DNDI North America is threefold. Firstly, it aims to contribute to achieving DNDI's global objectives by providing focused support for specific research and development projects, as well as business and partnership activities, in North America. Secondly, DNDI North America seeks to achieve concrete policy changes in North America that create a more favorable environment for needs-driven research and development for neglected diseases. Lastly, it strives to mobilize public and private funds in North America to support DNDI's mission, while increasing the organization's profile and visibility in the region, thereby drawing greater public attention to the need for neglected disease research and development.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
Drugs For Neglected Diseases Initiative North America Inc (DNDI North America) plays a critical role in addressing the global challenge of neglected diseases. By focusing on research and development (R&D), DNDI North America supports innovative projects aimed at creating new drugs or reformulations of existing treatments for patients affected by diseases that are often overlooked. With a commitment to bridging existing R&D gaps, DNDI North America collaborates across various sectors—including the international research community, public entities, and the pharmaceutical industry—to drive impactful drug development projects.
The initiative aims to deliver 25 new treatments by 2028, and it currently boasts over 30 projects in its pipeline, which includes more than 20 potential new chemical entities. Notably, DNDI has successfully brought 12 treatments for six life-threatening diseases to the market, benefiting millions of patients worldwide. Through its efforts in advocacy, policy change, and fundraising, DNDI North America seeks to create a more favorable environment for R&D dedicated to neglected diseases. By raising awareness and mobilizing resources, the organization enhances its profile and emphasizes the urgent need for effective treatments in this crucial area of public health.
This information is meant to be a general summary of Drugs For Neglected Diseases Initiative North America Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2023.
- Investment Income: $14,987
- Gross Receipts: $4,350,936
Assets and Liabilities:
- Total Assets: $1,155,455
- Total Liabilities: $229,562
- Net Assets: $925,893
Want to help this charity, for free? You can click here to learn more about Give Freely
Organization Details
If you are a representative of Drugs For Neglected Diseases Initiative North America Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.